BCDA
Price
$1.12
Change
-$0.04 (-3.45%)
Updated
Feb 4, 02:20 PM (EDT)
Capitalization
12.31M
Intraday BUY SELL Signals
SMMT
Price
$14.23
Change
-$0.36 (-2.47%)
Updated
Feb 4, 03:18 PM (EDT)
Capitalization
10.86B
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCDA vs SMMT

Header iconBCDA vs SMMT Comparison
Open Charts BCDA vs SMMTBanner chart's image
BioCardia
Price$1.12
Change-$0.04 (-3.45%)
Volume$100
Capitalization12.31M
Summit Therapeutics
Price$14.23
Change-$0.36 (-2.47%)
Volume$3.8K
Capitalization10.86B
BCDA vs SMMT Comparison Chart in %
BCDA
Daily Signal:
Gain/Loss:
SMMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCDA vs. SMMT commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a Buy and SMMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (BCDA: $1.16 vs. SMMT: $14.59)
Brand notoriety: BCDA and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 62% vs. SMMT: 126%
Market capitalization -- BCDA: $12.31M vs. SMMT: $10.86B
BCDA [@Biotechnology] is valued at $12.31M. SMMT’s [@Biotechnology] market capitalization is $10.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 1 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMT is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 5 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).

  • BCDA’s TA Score: 5 bullish, 5 bearish.
  • SMMT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BCDA and SMMT are a good buy in the short-term.

Price Growth

BCDA (@Biotechnology) experienced а -12.12% price change this week, while SMMT (@Biotechnology) price change was -8.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

SMMT is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($10.9B) has a higher market cap than BCDA($12.3M). BCDA YTD gains are higher at: -7.200 vs. SMMT (-16.581). BCDA has higher annual earnings (EBITDA): -8.55M vs. SMMT (-921.45M). SMMT has more cash in the bank: 239M vs. BCDA (5.29M). BCDA has less debt than SMMT: BCDA (638K) vs SMMT (5.43M). BCDA (0) and SMMT (0) have equivalent revenues.
BCDASMMTBCDA / SMMT
Capitalization12.3M10.9B0%
EBITDA-8.55M-921.45M1%
Gain YTD-7.200-16.58143%
P/E RatioN/A26.36-
Revenue00-
Total Cash5.29M239M2%
Total Debt638K5.43M12%
FUNDAMENTALS RATINGS
BCDA vs SMMT: Fundamental Ratings
BCDA
SMMT
OUTLOOK RATING
1..100
7668
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8289
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCDA's Valuation (83) in the null industry is in the same range as SMMT (93) in the Biotechnology industry. This means that BCDA’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

SMMT's SMR Rating (100) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

BCDA's Price Growth Rating (82) in the null industry is in the same range as SMMT (89) in the Biotechnology industry. This means that BCDA’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew significantly faster than BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDASMMT
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signal:
Gain/Loss:
SMMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UTSL41.521.80
+4.53%
Direxion Daily Utilities Bull 3X ETF
FTKI19.480.03
+0.16%
First Trust Small Cap Buywrite Income ETF
MNA36.110.03
+0.08%
NYLI Merger Arbitrage ETF
FRDD18.86N/A
N/A
Direxion Daily F Bear 1X ETF
PSI93.88-1.44
-1.51%
Invesco Semiconductors ETF

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with SMMT. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
-4.13%
SMMT - BCDA
68%
Closely correlated
+3.77%
XRTX - BCDA
43%
Loosely correlated
+2.53%
MDGL - BCDA
29%
Poorly correlated
-1.49%
INO - BCDA
28%
Poorly correlated
-0.59%
KOD - BCDA
28%
Poorly correlated
-0.33%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+3.77%
BCDA - SMMT
70%
Closely correlated
-4.13%
BNTX - SMMT
53%
Loosely correlated
-0.58%
TIL - SMMT
44%
Loosely correlated
-1.66%
IDYA - SMMT
44%
Loosely correlated
+0.50%
MGNX - SMMT
43%
Loosely correlated
N/A
More